Dengvaxia® Next Steps

Bergren, Nicholas

i

Dengvaxia® Next Steps

Public Domain

June 26, 2024
By Bergren, Nicholas
Series: ACIP meeting Respiratory Syncytial Virus Vaccines – Adult

File Language:

English

Details

Alternative Title:

Dengue Tetravalent Vaccine (Live, Attenuated) [Dengvaxia®] i
Personal Author:

Bergren, Nicholas
Corporate Authors:

Sanofi AstraZeneca
Description:

Dengue Tetravalent Vaccine (Live, Attenuated) [Dengvaxia®] is being discontinued due to low demand.

This decision is not due to any concerns regarding quality, safety or efficacy.

01-Denvaxia-Bergren-508.pdf
Subjects:

Dengue/prevention & Control Dengue Vaccines
Series:

ACIP meeting Respiratory Syncytial Virus Vaccines – Adult
Document Type:

Presentation
Name as Subject:

ACIP meeting: 2024 June 26-28 ; Dengvaxia®
Genre:

Conference Publications
Place as Subject:

United States
Pages in Document:

3 numbered slides
Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Main Document Checksum:

urn:sha256:c3b77c88bc58e9dd3a7efd337c167a739a2bebc3ac93c23652ac54fd4f5eb50b
Download URL:

https://stacks.cdc.gov/view/cdc/157848/cdc_157848_DS1.pdf
File Type:

[PDF - 132.70 KB ]

File Language:

English

ON THIS PAGE

Details Related Documents

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.